NCT02737449Active, not recruiting
CorEvitas Japan Rheumatoid Arthritis (RA) Registry
Source: ClinicalTrials.gov · Last updated 2 Oct 2025
Brief summary (registry, in English)
The primary objective is to prospectively study the comparative effectiveness and comparative safety of approved therapies for RA in a Japanese cohort of patients treated by rheumatologists. This includes assessing the incidence of adverse events of special interest, in a real-world population of rheumatoid arthritis patients. Secondary objectives include analyzing the epidemiology and natural history of the disease, comorbidities, and current treatment practices.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 31 Mar 2016
- Start date
- 1 Jul 2016
- Primary completion date
- 31 Dec 2100
- Lead sponsor
- CorEvitas
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT02737449
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 Jul 2016 to the primary completion date, 31 Dec 2100
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- The subject is unable or unwilling to provide informed consent to participate in the registry.
Who the study is looking for
- The subject must be diagnosed with rheumatoid arthritis according to the 1987 ACR or the ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria
- The subject must be at least 18 years of age or older
- The subject must be able and willing to provide written consent
- The subject must be prescribed or switching to an eligible medication for the first time ever at the Enrollment Visit. History of concomitant treatment with other eligible medications does not exclude a subject from enrollment.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.